Bearing Point Capital’s Astera Labs ALAB Stock Holding History

Bearing Point Capital’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,145	Closed	-$3.52M	–	188
2025 Q4	$3.52M	Buy	+21,145	New	+$3.54M	0.55%	58

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Bearing Point Capital's ALAB Position: Q1 2026 in Review

Bearing Point Capital sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 21,145 shares — an estimated $3.52M sold.

Bearing Point Capital first reported a position in ALAB in Q4 2025 and held it in 1 quarter. The position peaked at $3.52M in Q4 2025. 708 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

Bearing Point Capital reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
Bearing Point Capital sold 21,145 Astera Labs shares in Q1 2026, an estimated $3.52M.
Bearing Point Capital first reported a position in Astera Labs in Q4 2025 and held it in 1 quarter.
Bearing Point Capital's Astera Labs position peaked at $3.52M in Q4 2025.
708 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Bearing Point Capital's 13F filing for Q1 2026, filed 7 May 2026.